Symplavix Trademark Details

Symplavix was registered on Tuesday, December 15, 2009 and is currently owned by Sanofi under the registration number 3724910 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 7 years ago on Friday, July 22, 2016, according to the United State Patent & Trademark Office
Word Mark Symplavix
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Sanofi of Paris, TX

View all trademarks for Sanofi
Other Trademarks for Sanofi

Previous Owners

Sanofi-Aventis of Paris, TX

View all trademarks for Sanofi-Aventis
Other Trademarks for Sanofi-Aventis
Serial Number 77712830
Registration Number 3724910
Status Date Friday, July 22, 2016
Filing Date Friday, July 22, 2016
Registration Date Tuesday, December 15, 2009
Attorney Susan Upton Douglass
Domestic Representative Susan Upton Douglass

Correspondent

SUSAN UPTON DOUGLASS
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLZ
NEW YORK, NY 10017-1822

Case File Statements

Goods & Services Pharmaceutical substances and products for the prevention and the treatment of cardiovascular diseases

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, July 22, 2016
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.